Meiri AI Express, on the evening of February 24, Jiudian Pharmaceutical announced that as of the date of this announcement, the company has repurchased approximately 6.18 million shares through a dedicated securities account for share repurchase, accounting for 1.24% of the company’s current total share capital. The highest transaction price was 18.44 yuan per share, the lowest was 14.51 yuan per share, with a total transaction amount of about 100 million yuan.
Meiri Headlines (nbdtoutiao)—180,000 casualties! Four years of Russia-Ukraine conflict, stuck in deadlocked negotiations, stalemated battlefield, and economic crisis! Who is paying for the war?
(Reporter Wang Hanli)
Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Operate at your own risk.
Daily Economic News
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Jiadian Pharmaceutical: Cumulative repurchase of approximately 6.18 million shares
Meiri AI Express, on the evening of February 24, Jiudian Pharmaceutical announced that as of the date of this announcement, the company has repurchased approximately 6.18 million shares through a dedicated securities account for share repurchase, accounting for 1.24% of the company’s current total share capital. The highest transaction price was 18.44 yuan per share, the lowest was 14.51 yuan per share, with a total transaction amount of about 100 million yuan.
Meiri Headlines (nbdtoutiao)—180,000 casualties! Four years of Russia-Ukraine conflict, stuck in deadlocked negotiations, stalemated battlefield, and economic crisis! Who is paying for the war?
(Reporter Wang Hanli)
Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Operate at your own risk.
Daily Economic News